DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Polylactide, Processed by a Foaming Method Using Compressed Freon R134a, for Tissue Engineering
Fabricating polymeric scaffolds using cost-effective manufacturing processes is still challenging. Gas foaming techniques using supercritical carbon dioxide (scCO2) have attracted attention for producing synthetic polymer matrices; however, the high-pressure requirements are often a technological barrier for its widespread use. Compressed 1,1,1,2-tetrafluoroethane, known as Freon R134a, offers advantages over CO2 in manufacturing processes in terms of lower pressure and temperature conditions and the use of low-cost equipment. Here, we report for the first time the use of Freon R134a for generating porous polymer matrices, specifically polylactide (PLA). PLA scaffolds processed with Freon R134a exhibited larger pore sizes, and total porosity, and appropriate mechanical properties compared with those achieved by scCO2 processing. PLGA scaffolds processed with Freon R134a were highly porous and showed a relatively fragile structure. Human mesenchymal stem cells (MSCs) attached to PLA scaffolds processed with Freon R134a, and their metabolic activity increased during culturing. In addition, MSCs displayed spread morphology on the PLA scaffolds processed with Freon R134a, with a well-organized actin cytoskeleton and a dense matrix of fibronectin fibrils. Functionalization of Freon R134a-processed PLA scaffolds with protein nanoparticles, used as bioactive factors, enhanced the scaffolds' cytocompatibility. These findings indicate that gas foaming using compressed Freon R134a could represent a cost-effective and environmentally friendly fabrication technology to produce polymeric scaffolds for tissue engineering approaches., This work was supported by the Spanish Ministry of Economy and Competitiveness
(MOTHER MAT2016-80826-R and Mol4Bio PID2019-105622RBI00); Spanish Ministry of Science,
Innovation and Universities (RTI2018-095159-B-100); Instituto de Salud Carlos III (ISCIII)- European
Regional Development Fund (ERDF); MINECO-AES (PI15/00752, PI15/01118 and PI18/00643); the
Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN); CSIC
through grant 2019AEP133; Comunidad Autónoma de Madrid (grant S2013/MIT-2862); Generalitat
de Catalunya (grants 2017-SGR-918, 2017-SGR-229 and CERCA Programme); the Fundació Marató
de TV3 (Nr. 201812); the COST Action CA15126 Between Atom and Cell; and the European Social
Fund and EU to J.V., A.V. and I.R. (H2020-INFRAIA-2014-2015; NFFA-654360)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
Proyecto:
MICIU / Plan Estatal de investigación Científica y Técnica y de Innovación 2013-2016 MAT2016-80826-R
,
MICIU / Plan Estatal de investigación Científica y Técnica y de Innovación 2017-2020 PID2019-105622RBI00
,
MICIU / Plan Estatal de investigación Científica y Técnica y de Innovación 2017-2020 RTI2018-095159-B-100)
,
MICIU / Plan Estatal de investigación Científica y Técnica y de Innovación 2017-2020 CEX2019-000917-S
DOI: http://hdl.handle.net/10261/263513, https://api.elsevier.com/content/abstract/scopus_id/85117169315
HANDLE: http://hdl.handle.net/10261/263513, https://api.elsevier.com/content/abstract/scopus_id/85117169315